Bharat Biotech's Covaxin Approval Requested In US For Children Below 18 | Read

PUBLISHED ON: November 6, 2021 | Duration: 0 min, 55 sec

facebooktwitteremailkoo
loading..
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
ALSO WATCH
At Geneva Meet, India Says Disappointed Over WHO's Excess Deaths Report

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com